Point72 Asset Management’s Silence Therapeutics SLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,032
| Closed | -$45.2K | – | 1796 |
|
|
2025
Q1 | $45.2K | Sell |
16,032
-617,068
| -97% | -$1.74M | ﹤0.01% | 1197 |
|
|
2024
Q4 | $4.36M | Buy |
633,100
+165,300
| +35% | +$1.14M | 0.01% | 694 |
|
|
2024
Q3 | $8.5M | Buy |
467,800
+321,300
| +219% | +$5.84M | 0.02% | 532 |
|
|
2024
Q2 | $2.78M | Buy |
146,500
+138,300
| +1,687% | +$2.63M | 0.01% | 713 |
|
|
2024
Q1 | $177K | Buy |
+8,200
| New | +$177K | ﹤0.01% | 1230 |
|
|
2023
Q3 | – | Sell |
-86,700
| Closed | -$477K | – | 2130 |
|
|
2023
Q2 | $477K | Sell |
86,700
-262,762
| -75% | -$1.45M | ﹤0.01% | 913 |
|
|
2023
Q1 | $2.17M | Sell |
349,462
-21,100
| -6% | -$131K | 0.01% | 792 |
|
|
2022
Q4 | $5.65M | Sell |
370,562
-180,313
| -33% | -$2.75M | 0.02% | 617 |
|
|
2022
Q3 | $5.53M | Buy |
550,875
+300,875
| +120% | +$3.02M | 0.02% | 612 |
|
|
2022
Q2 | $2.96M | Hold |
250,000
| – | – | 0.01% | 703 |
|
|
2022
Q1 | $4.75M | Hold |
250,000
| – | – | 0.02% | 654 |
|
|
2021
Q4 | $5.97M | Buy |
+250,000
| New | +$5.97M | 0.02% | 597 |
|